| Report ID | 220886 |
| Drug Identification Number | 02496860 |
| Brand name | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION |
| Common or Proper name | BENDAMUSTINE HYDROCHLORIDE |
| Company Name | ACCORD HEALTHCARE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BENDAMUSTINE HYDROCHLORIDE |
| Strength(s) | 100MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | vial |
| ATC code | L01AA |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2024-02-27 |
| Estimated end date | |
| Actual end date | 2026-01-09 |
| Shortage status | Resolved |
| Updated date | 2026-01-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-01-13 | French | Compare |
| v3 | 2026-01-09 | English | Compare |
| v2 | 2024-02-28 | French | Compare |
| v1 | 2024-02-28 | English | Compare |
Showing 1 to 4 of 4